Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
Koens
Lianne
L
Senff
Nancy J
NJ
Vermeer
Maarten H
MH
Ronday
H Karel
HK
Willemze
Rein
R
Jansen
Patty M
PM
D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001706:Biopsy; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects*; D016410:Lymphoma, T-Cell, Cutaneous / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept